Sinovac Biotech Co., Ltd: Mouth Diseases trials

The registry lists 14 Mouth Diseases studies with Sinovac Biotech Co., Ltd as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 3 4Phase 4 5No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)RecruitingNCT06734832Phase 3
• Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in IndonesiaNot yet recruitingNCT06251219
• A Serosurvey Study of Hand, Foot, and Mouth Disease in IndonesiaCompletedNCT05637229
• Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in ShanghaiStatus unknownNCT05166044
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesCompletedNCT04111432Phase 4
• Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 MonthsCompletedNCT03909074Phase 3
• Efficacy Trial of a Commercial EV71 VaccineCompletedNCT03903926Phase 4
• Immunogenicity and Safety of Two Different Commercial EV71 VaccinesCompletedNCT03873740Phase 4
• Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT03281174
• Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedNCT03278132Phase 4
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI VaccinesCompletedNCT03274102Phase 4
• Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01636245Phase 3
• An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01507857Phase 3
• Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedNCT01273246Phase 1